Randomized phase III trial of adjuvant chemotherapy with gemcitabine vs S-1 in patients with resected pancreatic cancer.
Phase of Trial: Phase III
Latest Information Update: 02 Jun 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Registrational; Therapeutic Use
- Acronyms JASPAC-01
- 02 Jun 2016 Results published in The Lancet.
- 02 Jun 2016 Status changed from active, no longer recruiting to completed, as per an article published in The Lancet.
- 28 Jan 2013 Results were presented at the Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (Abstract No. 145), according to a Taiho Pharmaceutical media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History